Novozymes A/S (OTCMKTS:NVZMY) Sees Unusually-High Trading Volume – What’s Next?

Novozymes A/S (OTCMKTS:NVZMYGet Free Report) saw unusually-high trading volume on Friday . Approximately 641,172 shares changed hands during mid-day trading, an increase of 713% from the previous session’s volume of 78,904 shares.The stock last traded at $59.4450 and had previously closed at $58.53.

Novozymes A/S Stock Up 0.8%

The company has a current ratio of 1.61, a quick ratio of 1.00 and a debt-to-equity ratio of 0.26. The stock has a market capitalization of $24.46 billion, a PE ratio of 42.15, a P/E/G ratio of 1.08 and a beta of 1.10. The stock’s fifty day simple moving average is $62.71 and its 200-day simple moving average is $62.58.

Novozymes A/S (OTCMKTS:NVZMYGet Free Report) last announced its earnings results on Wednesday, February 25th. The biotechnology company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.79 by ($0.44). Novozymes A/S had a net margin of 13.96% and a return on equity of 6.38%. The firm had revenue of $1.18 billion during the quarter, compared to analysts’ expectations of $1.22 billion. As a group, sell-side analysts forecast that Novozymes A/S will post 1.82 EPS for the current fiscal year.

About Novozymes A/S

(Get Free Report)

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).

Featured Articles

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.